BDBM383231 4-(3-benzyl-3,4-dihydro-5- thia-1,2,2a1- triazaacenaphthylen-7-yl)-N- (1-methyl-1H-pyrazol-5- yl)pyrimidin-2-amine::US10278975, Compound I-16 R::US11376260, Example I-16R

SMILES Cn1nccc1Nc1nccc(n1)-c1cc2SC[C@H](Cc3ccccc3)c3nnc(c1)n23

InChI Key InChIKey=LFORTTKXDZPRME-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 383231   

TargetMitogen-activated protein kinase 1(Human)
Genentech

US Patent
LigandPNGBDBM383231(4-(3-benzyl-3,4-dihydro-5- thia-1,2,2a1- triazaace...)
Affinity DataIC50: 0.0200nMAssay Description:Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 6(Human)
Genentech

US Patent
LigandPNGBDBM383231(4-(3-benzyl-3,4-dihydro-5- thia-1,2,2a1- triazaace...)
Affinity DataIC50: 0.0200nMAssay Description:Compounds were tested in an enzymatic assay using human ERK-2 (Mitogen Activated Kinase 1), recombinantly expressed as an n-terminal 6-His fusion pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent